Factor Structure and Reliability of the Alzheimer's Disease Assessment Scale in a Multicenter Trial With Linopirdine

Abstract

The Alzheimer's Disease Assessment Scale (ADAS) has assumed a primary role in assessment of treatment responses in large-scale multicenter trials of drugs being evaluated for treatment of dementia in elderly patients. Data from 280 patients with Alzheimer's disease were analyzed to evaluate factor structure and reliability. Results confirm the presence of three primary factors interpreted as mental status, verbal fluency, and praxis. The presence of a large general factor underlying those more specific dimensions also supports the utility of the composite ADAS cognitive score that has been used as a primary outcome measure in previous drug trials. Test-retest reliability of the factor scores were calculated to be 0.83, 0.78, and 0.87. Test-retest reliability of the composite ADAS cognitive score was 0.90. Statistics useful for estimation of sample sizes for future multicenter trials are provided.

Get full access to this article

View all access options for this article.

References

1. Rosen WG , Mohs RC , Davis KL : A new rating scale for Alzheimer's disease. Am J Psychiatry 1984; 141:1356–1364.

2. Bagne CA , Pomara N , Crook T , Gershon S : Alzheimer's disease: Strategies for treatment and research, in Crook T , Bartus R , Ferris S , Gershon S (eds): Treatment Development Strategies for Alzheimer's Disease. Madison, CT, Mark Powley, 1986.

3. Davis KL , Hollister LE , Overall JE , et al: Physostigmine: Effects on cognition and affect in normal subjects. Psychopharmacology 1976; 51:23–27.

4. Davis KL , Mohs RC , Tinklenberg JR , et al: Physostigmine: Improvement of long-term memory processes in normal humans. Science 1978; 201:272–274.

5. Davis KL , Mohs RC : Enhancement of memory processes in Alzheimer's disease with multiple-dose intravenous physostigmine. Am J Psychiatry 1982; 139:1421–1424.

6. Mohs RC , Rosen WG , Greenwald BS , Davis KL : Neuropathologically validated scales for Alzheimer's disease, in Crook T , Ferris S , Bartus R (eds): Assessment in Geriatric Psychopharmacology. New Canaan, CT, Mark Powley, 1983.

7. Cattell RB : The Scientific Use of Factor Analysis in Beliavioral and Life Sciences. New York, Plenum Press, 1978.

8. Kaiser HF : A note on Guttman's lower bound for the number of common factors. Br J Stat Psychol 1961; 14:1.

9. Overall JE , Starbuck RR : Sample size estimation for randomized pre-post design. J Psychiatr Res 1979; 15:51–55.

10.

10. Folstein MF , Folstein SE , McHugh PR : Mini Mental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189–198.